Skip to Content

AmerisourceBergen Corp - Stock Quote ABC

Rating as of

Morningstar's AmerisourceBergen Corp Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

AmerisourceBergen Reports Strong Second-Quarter Results; Raising Our Fair Value Estimate to $155

Dylan Finley, CFA Equity Analyst

Analyst Note

| Dylan Finley, CFA |

Overall, we were pleased with AmerisourceBergen's solid performance during the fiscal second quarter, which benefited from a higher-than-expected contribution from COVID-19 treatment distribution. We are raising our fair value estimate to $155 per share from $151 to account for a nominal top- and bottom-line guidance increase by management and a slight uptick in our margin forecast for 2023. We are maintaining our long-term growth and margin expectations, with a slight improvement to operating profit in our 2023 forecast stemming from higher-margin COVID-19 treatment revenue.

Read Full Analysis

AmerisourceBergen Corp's Company Profile

Business Description

AmerisourceBergen is a leading pharmaceutical wholesaler engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Along with McKesson and Cardinal Health, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Through bolt-on acquisitions, the company has expanded into international wholesale in Europe (Alliance Healthcare). AmerisourceBergen provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health).

Contact
1 West First Avenue
Conshohocken, PA, 19428-1800
T +1 610 727-7000
Sector Healthcare
Industry Medical Distribution
Most Recent Earnings Mar 31, 2022
Fiscal Year End Sep 30, 2022
Stock Type Classic Growth
Employees 42,000

AmerisourceBergen Corp's Related Articles & News